Safety of valganciclovir 450 mg 3 times weekly for cytomegalovirus prophylaxis in solid organ transplant recipients requiring hemodialysis

Danielle Ecabert, Christine Pham, Brett J. Pierce, William L. Musick, Duc T. Nguyen, Edward A. Graviss

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of valganciclovir 450 mg 3 times weekly for cytomegalovirus prophylaxis in solid organ transplant recipients requiring hemodialysis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science